Navigation Links
Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
Date:5/31/2013

SEATTLE, May 31, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive results from its Phase 1 clinical program evaluating OMS824, the lead compound from its phosphodiesterase 10 (PDE10) program. This study measured the extent to which OMS824 binds to PDE10 in the basal ganglia, a region of the brain that has been linked to a wide range of diseases that affect cognition. The results show that the selected dose of OMS824 achieved approximately 50 percent occupancy of PDE10 without triggering the extrapyramidal symptoms (loss of muscle control, e.g., muscle rigidity, tremors, or involuntary muscle movements) reported as side effects with other PDE10 inhibitors that achieved similar or significantly lower occupancy levels. OMS824 is Omeros' proprietary compound that selectively inhibits PDE10, and the Company plans to advance into Phase 2 clinical trials in Huntington's disease and schizophrenia later this year.

The OMS824 Phase 1 clinical program previously evaluated the tolerability and pharmacokinetics of single and multiple doses of OMS824 in healthy subjects. OMS824 was well tolerated by all subjects, and the only apparent drug-related adverse event was mild somnolence at the highest dose evaluated. In the clinical trial reported today, positron emission tomography (PET) scans were used to measure the binding activity of OMS824 to PDE10 in the brains of healthy subjects who received once daily dosing of OMS824 for seven days.  Quantitation of PET images showed that approximately 50 percent occupancy of PDE10 in the basal ganglia was achieved by this dosing regimen. OMS824 was well tolerated and, consistent with earlier studies, mild somnolence was the only apparent adverse effect.

Other PDE10 inhibitors under development have been associated with extrapyramidal symptoms in humans at similar or substanti
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: Sepsis - ... Sepsis patients suffer from a series of diverse complications ... in the blood or tissues, which cause a rapidly ... to mortality rates near 50% depending on disease severity. ... healthcare systems of the global marketplace, which for the ...
(Date:5/27/2015)... -- PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - ... Event-Driven Update Summary The lupus therapeutics ... the only drug that has gained marketing approval for ... patients, uptake has remained low, but due to its ... lupus market in terms of value and is currently ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "Asia Pacific Ultrasound Devices ... - 2019)"  company profile to their ... , ,Ultrasound is a type of imaging. ... at body parts and structures inside the ...
Breaking Medicine Technology:OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2
... Meg Porfido, former chief human resources officer for Level ... Directors for Kaiser Foundation Hospitals and Kaiser Foundation Health ... to our Board will further diversify the outstanding talents ... George C. Halvorson, chairman and chief executive officer of ...
... 2011 Varian Medical Systems (NYSE: VAR ... system vendors in a 2011 performance report released last ... monitoring and reporting on the performance of healthcare technology ... a range of clinical, administrative, and financial activities in ...
Cached Medicine Technology:Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 2Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 3Varian Medical Systems' ARIA Ranked No. 1 in 2011 KLAS Report on Oncology IT Vendors 2Varian Medical Systems' ARIA Ranked No. 1 in 2011 KLAS Report on Oncology IT Vendors 3
(Date:5/27/2015)... Nursing Homes are starting to supplant hospitals as focus of ... April 2015 New York Times article. While Americans, in practice, ... years of research have documented the risks of hospitalization for ... both safer for older patients and less costly than hospitals. ... patients and family members may worry whether a nursing home ...
(Date:5/27/2015)... May 27, 2015 With the launch ... more robust Network Management Module (NMM) tool, monitoring provider-network ... 21 issue of Atlantic Information Services, Inc.’s (AIS) Medicare ... NMM tool, as well as analysis from industry experts ... The changes coming to the NMM were announced at ...
(Date:5/27/2015)... Marcos, CA (PRWEB) May 27, 2015 Allred ... solution to help patients - who need extensive dental treatment ... well as treatment options customized for their problems. , Dr. ... in a visual presentation of the assessment of the patient’s ... suitable options, which can treat their oral health problems. , ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a leading ... announced today that SanMar Corporation successfully implemented the ... and point tracking processes for over 3,000 employees ... , Family-owned since 1971, Seattle-based SanMar Corporation is ... and mill brands. SanMar supplies apparel and accessories ...
(Date:5/27/2015)... 2015 CURE® Magazine and ... mission is to advance research, provide information and support, ... to battle the fifth most common type of cancer, ... start to grow out of control. , “CURE ... every stage of the cancer experience through digital and ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3
... perform with, it would be British band Coldplay. ... and that's why he would give an arm and a leg ... Timberlake knows just who he wants to jam with - Gwyneth ... so I'd love to do a duet with them - especially ...
... systems have been deployed worldwide to provide early detection ... ,New methods that improve the overall detection capabilities ... However, most surveillance systems do not hold up when ... caused by public-health crises and major public events, such ...
... and Hull York Medical School has confirmed a link between ... is a vitamin that comes from vegetables such as spinach ... sunflower seeds as well as liver are rich sources of ... to bread or flour will decrease the number of babies ...
... shows that the work intended for global health is ... ,The research was conducted by a UW team including ... the School of Public Health and Community Medicine; Jennifer ... Weatherford, finance and administration director of the Department of ...
... of alcohol has found that a high percentage of ... youth .Many high school students consume alcohol both regularly ... sources of alcohol, individuals who illegally provide alcohol to ... ,Many types of social sources of alcohol are used ...
... review shows how nicotine patches can double ... that the antidepressants bupropion and nortriptyline aid long-term ... (e.g. fluoxetine) do not. ,Yet another ... UK by NICE), increased the odds of successful ...
Cached Medicine News:Health News:Global Health Enriching the States Economy 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3
... mid-sized chest freezer utilizes ultra-thin vacuum ... capacity without increasing the footprint. Patented ... extends compressor life. Bright LED display ... provided for remote user-supplied monitoring system. ...
... NU-5510 DHD AutoFlow Direct Heat Decontamination ... guarantying the greatest control of airborne ... at 95C wet decontamination and a ... useful for cell line changes and ...
... ultra-thin vacuum insulation panel technology, in ... increase storage capacity, while maintaining a ... or 3,336 samples. Patented heat accumulator ... and extends compressor life. Temperature and ...
... Advanced Series CO2 Incubators ... reliability. Microprocessor achieves precise temperature ... natural evaporation & RH% is ... CO2 and RH are displayed ...
Medicine Products: